دورية أكاديمية
أعرض في EDS

The Canadian Women's Heart Health Alliance ATLAS on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women - Chapter 8: Knowledge Gaps and Status of Existing Research Programs in Canada.

التفاصيل البيبلوغرافية
العنوان: The Canadian Women's Heart Health Alliance ATLAS on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women - Chapter 8: Knowledge Gaps and Status of Existing Research Programs in Canada.
المؤلفون: Clavel MA; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, Québec, Canada., Van Spall HGC; Department of Medicine, Department of Health Research Methods, Evidence, and Impact, McMaster University, Toronto, Ontario, Canada., Mantella LE; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada., Foulds H; College of Kinesiology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada., Randhawa V; Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada., Parry M; Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, Ontario, Canada., Liblik K; Department of Medicine, Kingston Health Science Center, Kingston, Ontario, Canada., Kirkham AA; Faculty of Kinesiology and Physical Education, University of Toronto, Toronto, Ontario, Canada.; Toronto Rehabilitation Institute (KITE), University Health Network, Toronto, Ontario, Canada., Cotie L; Toronto Rehabilitation Institute (KITE), University Health Network, Toronto, Ontario, Canada., Jaffer S; General Internal Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Bruneau J; Faculty of Nursing, Memorial University of Newfoundland and Labrador, St John, Newfoundland and Labrador, Canada., Colella TJF; Toronto Rehabilitation Institute (KITE), University Health Network, Toronto, Ontario, Canada., Ahmed S; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Dhukai A; Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, Ontario, Canada., Gomes Z; Faculty of Medicine, Division of Cardiology, Dalhousie University, Halifax, Nova Scotia, Canada., Adreak N; Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada., Keeping-Burke L; Department of Nursing and Health Sciences, University of New Brunswick, Saint John, New Brunswick, Canada., Limbachia J; Schulich School of Medicine, Western University, London, Ontario, Canada., Liu S; Section of Cardiology, Department of Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada., Jacques KE; Person with lived experience, Canadian Women's Heart Health Alliance, Ottawa, Ontario, Canada., Mullen KA; University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Mulvagh SL; Faculty of Medicine, Division of Cardiology, Dalhousie University, Halifax, Nova Scotia, Canada., Norris CM; Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada.
المصدر: CJC open [CJC Open] 2023 Nov 17; Vol. 6 (2Part B), pp. 220-257. Date of Electronic Publication: 2023 Nov 17 (Print Publication: 2024).
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101763635 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-790X (Electronic) Linking ISSN: 2589790X NLM ISO Abbreviation: CJC Open Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: New York : Elsevier Inc., [2019]-
مستخلص: Despite significant progress in medical research and public health efforts, gaps in knowledge of women's heart health remain across epidemiology, presentation, management, outcomes, education, research, and publications. Historically, heart disease was viewed primarily as a condition in men and male individuals, leading to limited understanding of the unique risks and symptoms that women experience. These knowledge gaps are particularly problematic because globally heart disease is the leading cause of death for women. Until recently, sex and gender have not been addressed in cardiovascular research, including in preclinical and clinical research. Recruitment was often limited to male participants and individuals identifying as men, and data analysis according to sex or gender was not conducted, leading to a lack of data on how treatments and interventions might affect female patients and individuals who identify as women differently. This lack of data has led to suboptimal treatment and limitations in our understanding of the underlying mechanisms of heart disease in women, and is directly related to limited awareness and knowledge gaps in professional training and public education. Women are often unaware of their risk factors for heart disease or symptoms they might experience, leading to delays in diagnosis and treatments. Additionally, health care providers might not receive adequate training to diagnose and treat heart disease in women, leading to misdiagnosis or undertreatment. Addressing these knowledge gaps requires a multipronged approach, including education and policy change, built on evidence-based research. In this chapter we review the current state of existing cardiovascular research in Canada with a specific focus on women.
(© 2023 The Authors.)
References: J Am Coll Cardiol. 2014 Sep 23;64(12):1202-13. (PMID: 25236511)
Circulation. 2011 Nov 8;124(19):2145-54. (PMID: 22064958)
JACC Cardiovasc Imaging. 2020 Mar;13(3):699-711. (PMID: 31422128)
BMJ Glob Health. 2021 May;6(5):. (PMID: 33986001)
N Engl J Med. 1991 Jul 25;325(4):274-6. (PMID: 2057027)
Can J Cardiol. 2021 Apr;37(4):560-571. (PMID: 33383166)
J Am Coll Cardiol. 2021 Feb 2;77(4):450-500. (PMID: 33342587)
J Am Coll Cardiol. 1998 Oct;32(4):1118-25. (PMID: 9768741)
CJC Open. 2021 Nov 23;4(3):243-262. (PMID: 35386135)
Circ Heart Fail. 2022 Mar;15(3):e008685. (PMID: 34911363)
JACC Cardiovasc Imaging. 2016 Apr;9(4):388-96. (PMID: 27056158)
J Obstet Gynaecol Can. 2017 Apr;39(4):229-268.e5. (PMID: 28413042)
J Am Heart Assoc. 2020 May 5;9(9):e014733. (PMID: 32363989)
Can J Cardiol. 2014 Dec;30(12):1482-91. (PMID: 25475448)
J Am Coll Cardiol. 2002 Sep 4;40(5):976-82. (PMID: 12225726)
J Am Coll Cardiol. 2016 Jan 19;67(2):136-138. (PMID: 26791058)
Int J Eat Disord. 2013 Jul;46(5):386-94. (PMID: 23658076)
Eur J Heart Fail. 2022 Sep;24(9):1532-1544. (PMID: 35596674)
Nat Rev Cardiol. 2021 Aug;18(8):537-538. (PMID: 34108677)
CJC Open. 2022 Apr 19;4(7):589-608. (PMID: 35865023)
Cardiol Res Pract. 2020 May 11;2020:3916361. (PMID: 32454998)
Am J Cardiol. 2018 Oct 1;122(7):1255-1259. (PMID: 30075895)
Lancet Planet Health. 2019 Dec;3(12):e511-e520. (PMID: 31868600)
Can J Cardiol. 2016 Jul;32(7):831-41. (PMID: 27343741)
Can J Cardiol. 2020 Mar;36(3):322-334. (PMID: 32145862)
J Obstet Gynaecol Can. 2010 Feb;32(2):113-119. (PMID: 20181311)
BMJ Glob Health. 2021 Nov;6(11):. (PMID: 34815246)
Milbank Q. 1998;76(4):517-63, 509. (PMID: 9879302)
Clin Ther. 2013 May;35(5):563-71. (PMID: 23490289)
J Immigr Minor Health. 2016 Feb;18(1):51-7. (PMID: 25894533)
Eur J Heart Fail. 2021 Sep;23(9):1488-1498. (PMID: 34302417)
Cardiol Rev. 2019 Mar/Apr;27(2):80-86. (PMID: 29634492)
J Am Coll Cardiol. 2021 Jul 13;78(2):189-192. (PMID: 34238440)
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9284-9291. (PMID: 32291335)
Can J Cardiol. 2019 Feb;35(2):107-132. (PMID: 30760415)
Eur Heart J. 2011 Jun;32(11):1313-5. (PMID: 21393339)
J Hypertens. 2014 Apr;32(4):724-34. (PMID: 24609208)
JACC Basic Transl Sci. 2019 Aug 26;4(4):471-477. (PMID: 31468001)
Semin Thorac Cardiovasc Surg. 2022 Winter;34(4):1233-1235. (PMID: 34454030)
Physiol Rep. 2022 Aug;10(16):e15433. (PMID: 36029186)
Lancet. 2018 Mar 10;391(10124):960-969. (PMID: 29536860)
Res Integr Peer Rev. 2016 May 03;1:2. (PMID: 29451543)
Can J Cardiol. 2022 Aug;38(8):1296-1299. (PMID: 35247469)
Can J Cardiol. 2018 Dec;34(12):1553-1563. (PMID: 30527143)
J Clin Hypertens (Greenwich). 2012 Apr;14(4):228-35. (PMID: 22458744)
J Am Heart Assoc. 2021 Nov 2;10(21):e022353. (PMID: 34689608)
Can J Cardiol. 2019 May;35(5):598-605. (PMID: 30910247)
Int J Cardiol. 2004 Jul;96(1):97-103. (PMID: 15203267)
J Am Coll Cardiol. 2018 May 29;71(21):2419-2430. (PMID: 29793631)
Circ Res. 2017 Feb 17;120(4):681-691. (PMID: 27879282)
Heart. 2022 Aug 11;108(17):1342-1350. (PMID: 35022210)
Med Care. 2001 Aug;39(8 Suppl 2):II46-54. (PMID: 11583121)
Can J Cardiol. 2017 Nov;33(11):1342-1433. (PMID: 29111106)
Eur Heart J. 2021 Jul 21;42(28):2724-2726. (PMID: 33686419)
Can J Cardiol. 2021 Dec;37(12):1886-1901. (PMID: 34217807)
J Am Coll Cardiol. 2003 Jan 15;41(2):307-14. (PMID: 12535827)
Chronic Dis Inj Can. 2012 Sep;32(4):200-7. (PMID: 23046802)
Can J Cardiol. 2016 Nov;32(11):1263-1282. (PMID: 27712954)
Ann Thorac Surg. 2022 Aug;114(2):561-566. (PMID: 35182515)
Can J Cardiol. 2021 Jul;37(7):980-991. (PMID: 33581193)
JAMA Netw Open. 2021 Sep 1;4(9):e2123026. (PMID: 34495341)
Curr Opin Ophthalmol. 2014 May;25(3):171-6. (PMID: 24638114)
J Am Coll Cardiol. 2019 Oct 22;74(16):2032-2043. (PMID: 31623760)
Can J Cardiol. 2015 Jan;31(1):3-16. (PMID: 25532421)
Can J Cardiol. 2017 Apr;33(4):471-477. (PMID: 28169090)
Maturitas. 2021 Feb;144:1-3. (PMID: 33358200)
J Am Coll Cardiol. 2002 May 15;39(10):1608-14. (PMID: 12020487)
J Am Coll Cardiol. 2022 Jul 5;80(1):89-92. (PMID: 35772919)
N Engl J Med. 2006 Jul 20;355(3):281-7. (PMID: 16855268)
J Womens Health (Larchmt). 2021 Sep;30(9):1253-1258. (PMID: 33667122)
Cardiol Clin. 2020 Feb;38(1):129-138. (PMID: 31753171)
J Card Fail. 2019 Jun;25(6):425-435. (PMID: 30877039)
Am Heart J. 2010 Jul;160(1):80-87.e3. (PMID: 20598976)
Circ Cardiovasc Imaging. 2013 Jan 1;6(1):40-7. (PMID: 23233744)
Can J Cardiol. 2021 Dec;37(12):2056-2066. (PMID: 34419614)
J Am Coll Cardiol. 2010 Mar 16;55(11):1057-65. (PMID: 20223363)
CJC Open. 2020 Jul 02;2(6):522-529. (PMID: 33305212)
J Obstet Gynaecol Can. 2021 Dec;43(12):1395-1405. (PMID: 34089904)
Can J Cardiol. 2018 Apr;34(4):390-399. (PMID: 29571423)
Can J Cardiol. 2018 Mar;34(3):214-233. (PMID: 29475527)
Appl Physiol Nutr Metab. 2012 Feb;37(1):127-37. (PMID: 22269025)
Ann Ist Super Sanita. 2016 Apr-Jun;52(2):154-7. (PMID: 27364388)
Can J Cardiol. 2020 Dec;36(12):1847-1948. (PMID: 33191198)
J Hum Hypertens. 2016 Apr;30(4):278-84. (PMID: 26063562)
Can J Cardiol. 2014 Aug;30(8):837-49. (PMID: 25064578)
J Am Coll Cardiol. 2021 Jun 15;77(23):2960-2972. (PMID: 34112322)
Aust N Z J Public Health. 2004 Oct;28(5):409-14. (PMID: 15707181)
Health Rep. 2015 Aug;26(8):10-6. (PMID: 26288317)
J Am Coll Cardiol. 2022 Apr 19;79(15):1506-1518. (PMID: 35422247)
Eur Heart J. 2011 Jun;32(11):1362-8. (PMID: 21406440)
Nat Rev Cardiol. 2011 Aug 30;8(11):612. (PMID: 21878881)
World J Cardiol. 2015 Jan 26;7(1):10-8. (PMID: 25632314)
BMJ Open. 2022 Feb 1;12(2):e051020. (PMID: 35105571)
Diabetologia. 2019 Sep;62(9):1550-1560. (PMID: 31317230)
Can J Cardiol. 2018 May;34(5):526-531. (PMID: 29731014)
Circ Heart Fail. 2021 Nov;14(11):e008548. (PMID: 34711072)
Can J Cardiol. 2021 Apr;37(4):531-546. (PMID: 33827756)
Eur J Heart Fail. 2021 Jan;23(1):15-24. (PMID: 33118664)
CMAJ. 2010 May 18;182(8):E301-10. (PMID: 20403888)
CMAJ Open. 2014 Jul 22;2(3):E183-91. (PMID: 25295238)
Eur Heart J Qual Care Clin Outcomes. 2017 Jul 1;3(3):198-207. (PMID: 28838086)
Can J Cardiol. 2020 May;36(5):596-624. (PMID: 32389335)
Curr Probl Cardiol. 2023 Mar;48(3):101549. (PMID: 36538996)
فهرسة مساهمة: Local Abstract: [Publisher, French] En dépit des avancées importantes de la recherche médicale et des efforts en santé publique, il reste des lacunes dans les connaissances sur la santé cardiaque des femmes sur les plans de l’épidémiologie, du tableau clinique, de la prise en charge, des résultats, de l’éducation, de la recherche et des publications. Du point de vue historique, la cardiopathie a d’abord été perçue comme une maladie qui touchait les hommes et les individus de sexe masculin. De ce fait, la compréhension des risques particuliers et des symptômes qu’éprouvent les femmes est limitée. Ces lacunes dans les connaissances posent particulièrement problème puisqu’à l’échelle mondiale la cardiopathie est la cause principale de décès chez les femmes. Jusqu’à récemment, la recherche en cardiologie, notamment la recherche préclinique et clinique, ne portait pas sur le sexe et le genre. Le recrutement souvent limité aux participants masculins et aux individus dont l’identité de genre correspond au sexe masculin et l’absence d’analyses de données en fonction du sexe ou du genre ont eu pour conséquence un manque de données sur la façon dont les traitements et les interventions nuisent aux patientes féminines et aux individus dont l’identité de genre correspond au sexe féminin, et ce, de façon différente. Cette absence de données a mené à un traitement sous-optimal et à des limites de notre compréhension des mécanismes sous-jacents de la cardiopathie chez les femmes, et est directement reliée à nos connaissances limitées, et à nos lacunes en formation professionnelle et en éducation du public. Le fait que les femmes ne connaissent souvent pas leurs facteurs de risque de maladies du cœur ou les symptômes qu’elles peuvent éprouver entraîne des retards de diagnostic et de traitements. De plus, le fait que les prestataires de soins de santé ne reçoivent pas la formation adéquate pour poser le diagnostic et traiter la cardiopathie chez les femmes les mène à poser un mauvais diagnostic ou à ne pas traiter suffisamment. Pour pallier ces lacunes de connaissances, il faut une approche à plusieurs volets, qui porte notamment sur l’éducation et les changements dans les politiques, et qui repose sur la recherche fondée sur des données probantes. Dans ce chapitre, nous passons en revue l’état actuel de la recherche existante sur les maladies cardiovasculaires au Canada, plus particulièrement chez les femmes.
تواريخ الأحداث: Date Created: 20240315 Latest Revision: 20240316
رمز التحديث: 20240316
مُعرف محوري في PubMed: PMC10935691
DOI: 10.1016/j.cjco.2023.11.013
PMID: 38487042
قاعدة البيانات: MEDLINE
الوصف
تدمد:2589-790X
DOI:10.1016/j.cjco.2023.11.013